FilingReader Intelligence

Cao Fei gains control of Hubei Jumpcan Pharmaceutical

July 31, 2025 at 09:11 AM UTCBy FilingReader AI

Cao Fei's tender offer for Hubei Jumpcan Pharmaceutical shares concluded with minimal uptake - only 16,300 of the 350.8 million shares sought were tendered at 24.85 yuan each.

Despite the low response, Cao Fei now directly and indirectly controls 56.07% of the pharmaceutical company's total share capital.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Hubei Jumpcan Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →